METHODS AND SYSTEMS OF TREATING PANCREATITIS PAIN CAUSED BY SPHINCTER OF ODDI DYSFUNCTION

• US 20090192557A1
• Filed: 01/22/2009
• Published: 07/30/2009
• Est. Priority Date: 01/23/2008
• Status: Active Grant

• Current Assignee: Boston Scientific Neuromodulation Corporation (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Neuromodulation Corporation (Boston Scientific Corporation)
• Inventors: Carbunaru, Rafael, Jaax, Kristen N., Whitehurst, Todd K., DiGiore, Andrew, Hastings, Roger, Schleicher, Brett, Baldwin, Greg
• Granted Patent: US 8,914,112 B2
• Time in Patent Office: Days
• US Class Current: 607/3
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control
• CPC Class Codes: A61N 1/36071 Pain
• CPC Class Codes: A61N 1/37205 Microstimulators, e.g. implantable through a cannula
• CPC Class Codes: A61N 1/37252 Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data

Abstract

Methods and systems of treating a patient with pancreatitis pain include providing a stimulator, configuring one or more stimulation parameters to control sphincter of Oddi function, programming the stimulator with the one or more stimulation parameters, generating a stimulus configured to control sphincter of Oddi function with the stimulator in accordance with the one or more stimulation parameters, and applying the stimulus with the stimulator to one or more stimulation sites in accordance with the one or more stimulation parameters.

Claims

1. A method of treating a patient with pancreatitis pain, comprising:

generating a stimulus with a stimulator implanted within the patient; and

applying the stimulus to a stimulation site comprising at least one or more of a region of the sphincter of Oddi and a nerve innervating a sphincter of Oddi of the patient, such that the applied stimulus controls the function of the sphincter of the Oddi to treat the pancreatitis pain.

2. The method of claim 1, wherein the stimulus contracts the sphincter of Oddi.

3. The method of claim 1, wherein the stimulus relaxes the sphincter of Oddi.

4. The method of claim 1, wherein the stimulation site comprises at least one or more of a sphincter of Oddi muscle tissue, a nerve innervating the sphincter of Oddi muscle tissue, a pre-ganglionic cholinergic nerve, an efferent nerve, a tissue of the duodenum near the sphincter of Oddi, and a pancreatic duct.

5. The method of claim 1, wherein the stimulus performs at least one of a blocking and an invoking of one or more myoelectrical potentials at the stimulation site.

6. The method of claim 1, wherein the stimulator is coupled to one or more electrodes, and wherein the stimulus comprises a stimulation current delivered via the electrodes.

7. The method of claim 1, wherein the stimulus comprises an infusion of one or more drugs at the stimulation site.

8. The method of claim 1, further comprising:

configuring one or more stimulation parameters designed to control the function of the sphincter of Oddi; and

programming the stimulator with the one or more stimulation parameters.

9. The method of claim 8, further comprising sensing at least one indicator related to the pancreatitis pain and using the at least one sensed indicator to adjust one or more of the stimulation parameters.

10. The method of claim 9, wherein the indicator comprises at least one or more of a contraction of one or more muscles of the sphincter of Oddi, a relaxation of one or more muscles of the sphincter of Oddi, a need for pancreatic secretion, a neurotransmitter level, a patient input, a change in hormone concentration, a detected stomach activity, a circumference change in a duodenum, a pyloric sphincter contraction, a detection of food passing through the gastrointestinal tract, a change in pH, an audible sound, a contraction of exocrine tissue, a pressure change in a bile duct, a change in myoelectrical potentials, a pressure change in a pancreatic duct, a pressure change in an ampulla, a pressure change in the duodenum, a circumference change in the pancreatic duct, a circumference change in the ampulla, and a circumference change in the duodenum.

11. The method of claim 9, further comprising sensing the at least one indicator with at least one or more of a patient feedback sensor, a hormonal sensor, a chemical sensor, a piezoelectric sensor, a strain gauge, an optical sensor, a pH sensor, an auditory sensor, and a pressure sensor.

12. The method of claim 1, further comprising implanting the stimulator within the patient.